PAVmed
-
Hospitals
PAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel Syndrome
November 28, 2017 NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that…
Read More » -
Extremities
PAVmed Successfully Completes CarpX™ Pre-Clinical Study
June 22, 2016 NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion…
Read More »